FDA Postponing Most Foreign Inspections Through April
The Food and Drug Administration is suspending foreign inspections through April, effective immediately, in response to the coronavirus outbreak, FDA said in a March 10 statement. “Inspections outside the U.S. deemed mission-critical will still be considered on a case-by-case basis,”…
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
it said. The decision comes as a result of recommendations from other agencies, including the State Department’s prohibition on travel by U.S. government employees. “We are aware of how this action may impact other FDA responsibilities, including product application reviews. We will be vigilant and monitor the situation very closely and will try to mitigate potential impacts from this outbreak in lockstep with the whole of the federal government,” FDA said. In the meantime, FDA will rely on other means to prevent entry of unsafe products, including records requests, examinations and product sampling at the border, it said.